🎁 Black Friday: up to 50% off of annual plans
Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
41.37
-2.28 (-5.22%)
At close: Nov 20, 2026, 4:00 PM EST
41.40
+0.03 (0.07%)
After-hours: Nov 20, 2026, 7:30 PM EST

Arrowhead Pharmaceuticals Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
450.82829.453.55240.74243.23
Revenue Growth
-45.65%23258.15%-98.52%-1.03%75.89%
Cost of Revenue
1.8----
Gross Profit
449.02829.453.55240.74243.23
Selling, General & Admin
432.4138.5113.44104.08132.44
Research & Development
723.79592.6491.19341.66289.3
Operating Expenses
1,156731.1604.63445.74421.74
Operating Income
-707.1798.35-601.08-205-178.51
Interest Expense
-93.71-89.36-32.35-18.33-
Interest & Investment Income
57.8637.2922.7215.35.03
Earnings From Equity Investments
-3.88----
Other Non Operating Income (Expenses)
3.985.26-1.751.540.77
EBT Excluding Unusual Items
-742.9251.53-612.46-206.49-172.71
Gain (Loss) on Sale of Assets
19----
Pretax Income
-723.9251.53-612.46-206.49-172.71
Income Tax Expense
-6.7821.42-2.772.783.79
Earnings From Continuing Operations
-717.1330.11-609.69-209.28-176.49
Minority Interest in Earnings
-7.07-31.7510.240.43
Net Income
-724.21-1.63-599.49-205.28-176.06
Net Income to Common
-724.21-1.63-599.49-205.28-176.06
Net Income Growth
-----
Shares Outstanding (Basic)
142134120107105
Shares Outstanding (Diluted)
142134120107105
Shares Change
5.89%11.67%12.21%1.26%1.62%
EPS (Basic)
-5.11-0.01-5.00-1.92-1.67
EPS (Diluted)
-5.11-0.01-5.00-1.92-1.67
EPS Growth
-----

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Free Cash Flow
-283.94156.89-604.32-330.63-188.91
Free Cash Flow Per Share
-2.001.17-5.04-3.10-1.79
Gross Margin
99.60%100.00%100.00%100.00%100.00%
Operating Margin
-156.86%11.86%-16927.06%-85.16%-73.39%
Profit Margin
-160.64%-0.20%-16882.37%-85.27%-72.39%
Free Cash Flow Margin
-62.98%18.92%-17018.31%-137.34%-77.67%
EBITDA
-680.55122.27-582.49-192.51-168.09
EBITDA Margin
-150.96%14.74%--79.97%-69.11%
D&A For EBITDA
26.6223.9318.612.4910.42
EBIT
-707.1798.35-601.08-205-178.51
EBIT Margin
-156.86%11.86%--85.16%-73.39%
Effective Tax Rate
-41.56%---
Revenue as Reported
450.82829.453.55--
SEC Filings: 10-K · 10-Q